These Analysts Slash Their Forecasts On Marvell Technology Following Q2 Results

Marvell Technology (MRVL) reported a Q2 EPS beat with $0.67 per share, though revenue of $2.006 billion slightly missed estimates despite a 58% year-over-year increase. Crucially, the company issued Q3 sales guidance with a midpoint below analyst expectations, tempering the outlook. Despite this mixed guidance, MRVL shares gained 3.3%, though several analysts subsequently lowered price targets while largely maintaining Buy ratings, indicating cautious optimism.

Analysis

Marvell Technology reported a mixed second quarter, characterized by a marginal earnings beat and a slight revenue miss. The company posted quarterly EPS of $0.67, narrowly exceeding the $0.66 analyst estimate, while revenue of $2.006 billion fell just short of the $2.009 billion consensus. Despite the miss against estimates, revenue grew an impressive 58% year-over-year. The primary concern stems from the third-quarter outlook, where the revenue guidance midpoint of approximately $2.06 billion is below the $2.105 billion analyst estimate, signaling potential near-term headwinds. This contrasts with a more positive Q3 EPS guidance range of $0.69-$0.79, which at its midpoint is above the $0.72 estimate, suggesting management's confidence in margin expansion. The market initially reacted positively, with shares gaining 3.3%, but this was met with a wave of caution from analysts who, despite largely maintaining Buy ratings, uniformly lowered price targets. The downgrade from BofA Securities to Neutral from Buy is a notable outlier, indicating a more significant recalibration of a major institution's outlook.

Key Decisions for Investors

• Investors should weigh the strong 58% year-over-year growth against the weaker-than-expected Q3 revenue guidance, which may signal a near-term top in growth momentum.
• The widespread price target reductions, including a downgrade to Neutral by BofA Securities, suggest that Wall Street is repricing near-term risk, warranting caution for new investors until the revenue trajectory becomes clearer.
• Monitor the company's ability to deliver on its guided Q3 earnings expansion, as achieving higher EPS on softer revenue would validate management's claims of strong operational margin control and could support the stock.